Marshall Wace’s MaxCyte MXCT Stock Holding History

Marshall Wace’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.2K	Buy	+98,912	New	+$92.3K	﹤0.01%	2943
2025 Q4	–	Sell	-12,354	Closed	-$19.5K	–	3292
2025 Q3	$19.5K	Sell	12,354 -116,954	-90%	-$203K	﹤0.01%	2783
2025 Q2	$282K	Buy	+129,308	New	+$313K	﹤0.01%	2346
2025 Q1	–	Sell	-252,333	Closed	-$1.05M	–	2929
2024 Q4	$1.05M	Buy	252,333 +29,739	+13%	+$112K	﹤0.01%	1709
2024 Q3	$866K	Sell	222,594 -277,075	-55%	-$1.17M	﹤0.01%	1705
2024 Q2	$1.96M	Buy	+499,669	New	+$2.15M	﹤0.01%	1381
2022 Q3	–	Sell	-257,068	Closed	-$1.22M	–	3644
2022 Q2	$1.22M	Buy	+257,068	New	+$1.27M	﹤0.01%	2324
2022 Q1	–	Sell	-986,437	Closed	-$10.1M	–	3771
2021 Q4	$10.1M	Buy	+986,437	New	+$10.6M	0.02%	860

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Marshall Wace's MXCT Position: Q1 2026 in Review

Marshall Wace opened a new position in MaxCyte (MXCT) in Q1 2026: 98,912 shares worth $69.2K. The stake represents ﹤0.01% of the portfolio and ranks #2943 among its holdings. This is a return to the name: Marshall Wace previously reported a position in MXCT as recently as Q3 2025.

Marshall Wace first reported a position in MXCT in Q4 2021 and has held it in 8 quarters since. The position peaked at $10.1M in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Marshall Wace held 98,912 shares of MaxCyte worth $69.2K as of Q1 2026.
MaxCyte was a new Marshall Wace position in Q1 2026.
MaxCyte made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2943 holding.
Marshall Wace first reported a position in MaxCyte in Q4 2021 and has held it in 8 quarters since.
Marshall Wace's MaxCyte position peaked at $10.1M in Q4 2021.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.